Cerevel Therapeutics Holdings, Inc.
Cerevel Therapeutics Holdings, Inc.（CERE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cere · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2025年8月27日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Hold
16 位分析师
共识
评级分布
12 个月目标价
High
$40.00
Consensus
$33.50
-25.5% upside
Low
$27.00
Median: $33.5 · Last Close: $44.96
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$33.50
-25.5% upside
High Target
$40
-11.0%
Low Target
$27
-39.9%
Current Price
$44.96
as of today
Based on analyst price targets, the CERE stock price prediction for the next 12 months ranges from $27 to $40. The consensus CERE price forecast of $33.50 implies -25.5% upside from the current price of $44.96.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $46.16 | ↑ 2.67% |
1-day model range: $46.02–$46.3. Peak: $46.3 (+2.67%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $55 | +23.1% |
| 2028 | $63 | +40.1% |
| 2029 | $68 | +51.8% |
| 2030 | $72 | +59.4% |
| 2031 | — | +64.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CERE · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-02-16 | Mizuho | Maintains | Neutral→Neutral |
| 2023-12-28 | JP Morgan | Maintains | Neutral→Neutral |
| 2023-12-22 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2023-12-08 | TD Cowen | Downgrade ↓ | Outperform→Market Perform |
| 2023-12-07 | Piper Sandler | Downgrade ↓ | Overweight→Neutral |
| 2023-12-07 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2023-12-07 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2023-08-07 | Mizuho | Maintains | Neutral→Neutral |
| 2023-08-06 | Mizuho | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Cerevel Therapeutics Holdings, Inc. (CERE) stock. Of the recent 78 rating actions, 2 were upgrades and 13 were downgrades. 16 analysts currently cover CERE.
分析师推荐趋势
CERE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$14M
EPS This Year
$-2.91
EPS Next Year
$-3.15
↑ 8.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast CERE EPS of $-2.91 for the current fiscal year, based on estimates from 4 analysts. The CERE revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CERE 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CERE 的共识目标价为 $33.50（-25.5% 上行空间），分析师共识为 Hold。
CERE 的短期预测（明日）为 $46.16（+2.67%）。 CERE 对 2027 年的股价预测均值为 $55。 CERE 对 2030 年的预测区间为 $69–$74。
Cerevel Therapeutics Holdings, Inc. 在 NASDAQ 上市，代码 CERE。CERE 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 38% 对应 Hold 共识。
常见问题
CERE 预测 · 8 个问题根据 16 位华尔街分析师，CERE 的 12 个月平均目标价为 $33.50，最高 $40.00、最低 $27.00。若有图表，中位目标价可在上方查看。相对当前价 $44.96，隐含约 -25.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.